Erratum to Signaling through the Short Form of Its Receptor Represses Forkhead Transcription Factor FOXO3 and Its Target Gene galt Causing a Severe Ovarian Defect. (Molecular Endocrinology (2008), 22, (513-522), 10.1210/me.2007-0399);Prolactin signaling through the short form of its receptor represses forkhead transcription factor FOXO3 and its target gene Galt causing a severe ovarian defect

Molecular Endocrinology

Volumn 22, Issue 2, 2008, Pages 513-522

  Halperin, Julia ^a   Devi, Sangeeta Y ^a   Elizur, Shai ^a   Stocco, Carlos ^a   Shehu, Aurora ^a   Rebourcet, Diane ^d   Unterman, Terry G ^b,c   Leslie, Nancy D ^e   Le, Jamie ^a   Binart, Nadine ^d   Gibori, Geula ^a,f  

^a Department of Pharmacology and the Comprehensive Cancer Center   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

^d INSERM   (France)

^e UNIVERSITY OF CINCINNATI   (United States)

^f M/C 901 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; PROLACTIN; TRANSCRIPTION FACTOR FKHRL1;

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; MOUSE; NONHUMAN; OVARY DEVELOPMENT; OVARY DISEASE; OVARY FOLLICLE DEVELOPMENT; PATHOGENESIS; PHENOTYPE; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MUS; MUS MUSCULUS;

EID: 38749095854     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2013-1306     Document Type: Erratum

References (37)

1. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA 1998 Prolactin (PRL) and its receptor: actions signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19:225-268
2. Freeman ME, Kanyicska B, Lerant A, Nagy G 2000 Prolactin: structure, function, and regulation of secretion. Physiol Rev 80:1523-1631
3. Ben-Jonathan N, Mershon JL, Steinmetz RW 1996 Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 17:639-669
4. Prigent-Tessier A, Tessier C, Hirosawa-Takamori M, Boyer C, Ferguson Gottschall S, Gibori G 1999 Rat decidual prolactin. Identification, molecular cloning, and characterization. J Biol Chem 274:37982-37989
5. Hugo ER, Brandebourg TD, Comstock CE, Gersin KS, Sussman JJ, Ben-Jonathan N 2006 LS14: a novel human adipocyte cell line that produces prolactin. Endocrinology 14:306-313
6. Davis JA, Linzer DI 1989 Expression of multiple forms of the prolactin receptor in mouse liver. Mol Endocrinol 3:674-680
7. Telleria CM, Parmer TG, Zhong L, Clarke DL, Albarracin CT, Duan WR, Linzer DIH, Gibori G 1997 The different forms of the prolactin receptor in the rat corpus luteum: developmental expression and hormonal regulation in pregnancy. Endocrinology 138:4812-4820
8. Clarke DL, Arey BJ, Linzer DIH 1993 Prolactin receptor messenger ribonucleic acid expression in the ovary during the rat estrous cycle. Endocrinology 133:2594-2603
9. Russell DL, Richards JS 1999 Differentiation-dependent prolactin responsiveness and STAT (signal transducers and activators of transcription) signaling in rat ovarian cells. Mol Endocrinol 13:2049-2064
10. Buck K, Vanek M, Groner B, Ball RK 1992 Multiple forms of prolactin receptor messenger ribonucleic acid are specifically expressed and regulated in murine tissues and the mammary cell line HC11. Endocrinology 130:1108-1114
11. Frasor J, Brakai U, Zhong L, Fazleabas AT, Gibori G 2001 PRL-induced ERα gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase. Mol Endocrinol 15:1941-1952
12. Berlanga JJ, Fresno Vara JA, Martin-Perez J, Garcia-Ruiz JP 1995 Prolactin receptor is associated with c-src kinase in rat liver. Mol Endocrinol 9:1461-1467
13. Fresno Vara JA, Caceres MA, Silva A, Martin-Perez J 2001 Src family kinases are required for prolactin induction of cell proliferation. Mol Biol Cell 7:2171-2183
14. Tessier C, Prigent-Tessier A, Ferguson-Gottschall S, Gu Y, Gibori G 2001 PRL antiapoptotic effect in the rat decidua involves the PI3K/protein kinase B-mediated inhibition of caspase-3 activity. Endocrinology 9:4086-4094
15. Nemeth E, Bole-Feysot C, Tashima LS 1998 Suppression subtractive hybridization (SSH) identifies prolactin stimulation of p38 MAP kinase gene expression in Nb2 T lymphoma cells: molecular cloning of rat p38 MAP kinase. Mol Cell Endocrinol 20:151-156
16. Lesueur L, Edery M, Ali S, Paly J, Kelly PA, Djiane J 1991 Comparison of long and short forms of the prolactin receptor on prolactin-induced milk protein gene transcription. Proc Natl Acad Sci USA 88:824-828
17. Berlanga JJ, Garcia-Ruiz JP, Perrot-Applanatt M, Kelly PA, Edery M 1997 The short form of the prolactin (PRL) receptor silences PRL induction of the β-casein gene promoter. Mol Endocrinol 11:1449-1457
18. Perrot-Applanatt M, Gualillo O, Pezet A, Vincent V, Edery M, Kelly PA 1997 Dominant negative and cooperative effects of mutant forms of prolactin receptor. Mol Endocrinol 11:1020-1032
19. Saunier E, Dif F, Kelly PA, Edery M 2003 Targeted expression of the dominant-negative prolactin receptor in the mammary gland of transgenic mice results in impaired lactation. Endocrinology 144:2669-2675
20. Binart N, Imbert-Bolloré P, Baran N, Viglietta C, Kelly PA 2003 A short form of the prolactin (PRL) receptor is able to rescue mammopoiesis in heterozygous PRL receptor mice. Mol Endocrinol 17:1066-1074
21. Stocco C, Telleria C, Gibori G 2006 The molecular control of corpus luteum formation, function, and regression. Endocr Rev 28:117-149
22. Risk M, Gibori G 2001 Mechanisms of luteal cell regulation by prolactin. In: Horseman ND, ed. Prolactin. Boston: Kluwer; 265-295
23. Ormandy CJ, Camus A, Barra J, Damotte D, Lucas B, Buteau H, Edery M, Brousse N, Babinet C, Binart N, Kelly PA 1997 Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev 11:167-178
24. Grosdemouge I, Bachelot A, Lucas A, Baran N, Kelly PA, Binart N 2003 Effects of deletion of the prolactin receptor on ovarian gene expression. Reprod Biol Endocrinol 1:12
25. Castrillon DH, Miao L, Kollipara R, Horner JW, DePinho RA 2003 Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 301:215-218
26. Hosaka T, Biggs WH, Tieu D, Boye AD, Varki NM, Cavenee WK, Arden KC 2004 Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci USA 101:2975-2980
27. Forges T, Monnier-Barbarino P, Leheup B, Jouvet P 2006 Pathophysiology of impaired ovarian function in galactosaemia. Hum Reprod Update 12:573-584
28. Binart N, Helloco C, Ormandy CJ, Barra J, Clément-Lacroix P, Baran N, Kelly PA 2000 Rescue of preimplantatory egg development and embryo implantation in prolactin receptor-deficient mice after progesterone administration. Endocrinology 141:2691-2697
29. Schuff KG, Hentges ST, Kelly MA, Binart N, Kelly PA, Iuvone PM, Asa SL, Low MJ 2002 Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms. J Clin Invest 110:973-981
30. Kaufman FR, Kogut MD, Donnell GN, Koch R, Goebelsmann U 1979 Ovarian failure in galactosaemia. Lancet 2:737-738
31. 2-macroglobulin, and decidual PRL involving the Jak2 and Stat5 pathway. Endocrinology 142:1242-1250
32. Onuma H, Vander Kooi BT, Boustead JN, Oeser JK, O'Brien RM 2006 Correlation between FOXO1a (FKHR) and FOXO3a (FKHRL1) binding and the inhibition of basal glucose-6-phosphatase catalytic subunit gene transcription by insulin. Mol Endocrinol 20:2831-2847
33. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME 1999 Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868
34. Liu G, Hale GE, Hughes CL 2000 Galactose metabolism and ovarian toxicity. Reprod Toxicol 14:377-384
35. Leslie ND 2003 Insights into the pathogenesis of galactosemia. Annu Rev Nutr 23:59-80
36. Liu L, Rajareddy S, Reddy P, Du C, Jagarlamudi K, Shen Y, Gunnarsson D, Selstam G, Boman K, Kiu K 2007 Infertility caused by retardation of follicular development in mice with oocyte-specific expression of Foxo3a. Development 134:199-209
37. Greer EL, Brunet A 2005 FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24:7410-7425